Sorafenib in platinum-treated patients with extensive stage small cell lung cancer: a Southwest Oncology Group (SWOG 0435) phase II trial.

Gitlitz, Barbara J

Sorafenib in platinum-treated patients with extensive stage small cell lung cancer: a Southwest Oncology Group (SWOG 0435) phase II trial. [electronic resource] - Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer Nov 2010 - 1835-40 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural

1556-1380

10.1097/JTO.0b013e3181f0bd78 doi


Adult
Aged
Aged, 80 and over
Antineoplastic Agents--therapeutic use
Benzenesulfonates--therapeutic use
Drug Resistance, Neoplasm--drug effects
Female
Humans
Lung Neoplasms--drug therapy
Male
Middle Aged
Neoplasm Recurrence, Local--diagnosis
Neoplasm Staging
Niacinamide--analogs & derivatives
Organoplatinum Compounds--therapeutic use
Phenylurea Compounds
Pyridines--therapeutic use
Remission Induction
Salvage Therapy
Small Cell Lung Carcinoma--drug therapy
Sorafenib
Survival Rate
Treatment Outcome